Stryker Corporation $SYK Shares Acquired by Waverly Advisors LLC

Waverly Advisors LLC increased its holdings in Stryker Corporation (NYSE:SYK) by 3.7% during the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 45,828 shares of the medical technology company’s stock after buying an additional 1,627 shares during the period. Waverly Advisors LLC’s holdings in Stryker were worth $15,059,000 as of its most recent SEC filing.

A number of other large investors have also recently added to or reduced their stakes in the business. Godfrey Financial Associates Inc. acquired a new position in Stryker during the fourth quarter worth about $26,000. Sankala Group LLC acquired a new stake in shares of Stryker in the fourth quarter valued at approximately $26,000. United Financial Planning Group LLC purchased a new position in shares of Stryker during the 3rd quarter worth approximately $27,000. Atlas Capital Advisors Inc. acquired a new position in shares of Stryker during the 4th quarter worth approximately $27,000. Finally, DJE Kapital AG acquired a new position in shares of Stryker during the 4th quarter worth approximately $28,000. 77.09% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

SYK has been the topic of a number of analyst reports. Robert W. Baird set a $385.00 target price on Stryker in a report on Friday, May 1st. JPMorgan Chase & Co. reduced their price objective on Stryker from $445.00 to $400.00 and set an “overweight” rating on the stock in a research report on Friday, May 1st. Leerink Partners decreased their price objective on Stryker from $410.00 to $407.00 and set an “outperform” rating on the stock in a research note on Friday, June 5th. BMO Capital Markets started coverage on shares of Stryker in a research note on Wednesday, July 8th. They issued an “outperform” rating and a $369.00 target price for the company. Finally, Evercore set a $350.00 target price on shares of Stryker in a report on Monday, July 6th. One research analyst has rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating and six have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $392.52.

Insider Buying and Selling

In other Stryker news, Director Ronda E. Stryker sold 310,000 shares of the stock in a transaction that occurred on Tuesday, May 26th. The shares were sold at an average price of $312.23, for a total transaction of $96,791,300.00. Following the transaction, the director owned 1,924,880 shares of the company’s stock, valued at $601,005,282.40. This trade represents a 13.87% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, VP M Kathryn Fink sold 5,220 shares of Stryker stock in a transaction on Monday, May 11th. The shares were sold at an average price of $283.85, for a total transaction of $1,481,697.00. Following the completion of the transaction, the vice president owned 13,137 shares in the company, valued at approximately $3,728,937.45. This trade represents a 28.44% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last quarter, insiders sold 323,264 shares of company stock valued at $100,659,489. Insiders own 4.60% of the company’s stock.

Stryker Price Performance

Shares of NYSE:SYK opened at $330.69 on Monday. The company has a market cap of $126.78 billion, a P/E ratio of 38.27, a P/E/G ratio of 2.12 and a beta of 0.77. The business has a fifty day simple moving average of $314.69 and a 200-day simple moving average of $335.57. Stryker Corporation has a 52 week low of $281.00 and a 52 week high of $404.14. The company has a quick ratio of 1.25, a current ratio of 2.11 and a debt-to-equity ratio of 0.62.

Stryker (NYSE:SYK) last issued its quarterly earnings results on Thursday, April 30th. The medical technology company reported $2.60 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $2.98 by ($0.38). The business had revenue of $6.02 billion during the quarter, compared to analyst estimates of $6.34 billion. Stryker had a return on equity of 23.42% and a net margin of 13.20%.The firm’s quarterly revenue was up 2.6% on a year-over-year basis. During the same period in the previous year, the business posted $2.84 earnings per share. Stryker has set its FY 2026 guidance at 14.900-15.100 EPS. Equities research analysts forecast that Stryker Corporation will post 14.99 EPS for the current year.

Stryker Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Tuesday, June 30th will be issued a $0.88 dividend. This represents a $3.52 dividend on an annualized basis and a yield of 1.1%. The ex-dividend date is Tuesday, June 30th. Stryker’s payout ratio is presently 40.74%.

Stryker Profile

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.